BR9610359A - 1.ar(alqu)il-imidazolin-2-onas de ação anticonvulsiva que contêm um radical amino dissubstituído em posição 4 e processo para sua preparação - Google Patents

1.ar(alqu)il-imidazolin-2-onas de ação anticonvulsiva que contêm um radical amino dissubstituído em posição 4 e processo para sua preparação

Info

Publication number
BR9610359A
BR9610359A BR9610359A BR9610359A BR9610359A BR 9610359 A BR9610359 A BR 9610359A BR 9610359 A BR9610359 A BR 9610359A BR 9610359 A BR9610359 A BR 9610359A BR 9610359 A BR9610359 A BR 9610359A
Authority
BR
Brazil
Prior art keywords
imidazolin
ones
alkyl
contain
preparation
Prior art date
Application number
BR9610359A
Other languages
English (en)
Inventor
Hans-Joachim Lankau
Manfred Menzer
Klaus Unverferth
Karl Gewald
Harry Schaefer
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9610359(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of BR9610359A publication Critical patent/BR9610359A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9610359A 1995-09-05 1996-07-26 1.ar(alqu)il-imidazolin-2-onas de ação anticonvulsiva que contêm um radical amino dissubstituído em posição 4 e processo para sua preparação BR9610359A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung
PCT/EP1996/003295 WO1997009314A1 (de) 1995-09-05 1996-07-26 Neue, antikonvulsiv wirkende 1-ar(alk)yl-imidazolin-2-one, die in 4-stellung einen disubstituierten amin-rest enthalten, und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BR9610359A true BR9610359A (pt) 1999-07-06

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610359A BR9610359A (pt) 1995-09-05 1996-07-26 1.ar(alqu)il-imidazolin-2-onas de ação anticonvulsiva que contêm um radical amino dissubstituído em posição 4 e processo para sua preparação

Country Status (32)

Country Link
EP (1) EP0863880B1 (pt)
JP (1) JP4030578B2 (pt)
CN (1) CN1103762C (pt)
AR (1) AR003502A1 (pt)
AT (1) ATE254606T1 (pt)
AU (1) AU700602B2 (pt)
BG (1) BG63917B1 (pt)
BR (1) BR9610359A (pt)
CA (1) CA2184871C (pt)
CZ (1) CZ291839B6 (pt)
DE (2) DE19532668A1 (pt)
DK (1) DK0863880T3 (pt)
EA (1) EA000535B1 (pt)
EE (1) EE03562B1 (pt)
ES (1) ES2208758T3 (pt)
FR (1) FR13C0049I2 (pt)
GE (1) GEP20022652B (pt)
HK (1) HK1015776A1 (pt)
HU (1) HU225956B1 (pt)
IL (1) IL123333A (pt)
LT (1) LT4482B (pt)
LU (1) LU92263I2 (pt)
NO (1) NO313829B1 (pt)
NZ (1) NZ315624A (pt)
PL (1) PL188287B1 (pt)
PT (1) PT863880E (pt)
SK (1) SK284868B6 (pt)
TR (1) TR199800476T1 (pt)
TW (1) TW422838B (pt)
UA (1) UA46790C2 (pt)
WO (1) WO1997009314A1 (pt)
ZA (1) ZA967014B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
UA87982C2 (ru) * 2003-07-11 2009-09-10 Берингер Ингельхайм Ветмедика Гмбх Способ лечения или предотвращения расстройств центральной нервной системы производными 1-ар(алк)-4-пиперидиноимидазолин-2-она, фармацевтическая композиция
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
RU2014109079A (ru) 2011-08-12 2015-09-20 Бёрингер Ингельхайм Ветмедика Гмбх Фармацевтическая композиция с маскированным вкусом
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
EP0863880A1 (de) 1998-09-16
EE9800063A (et) 1998-08-17
PL325413A1 (en) 1998-07-20
ZA967014B (en) 1997-08-18
DE59610827D1 (de) 2003-12-24
CZ66198A3 (cs) 1998-07-15
EP0863880B1 (de) 2003-11-19
TR199800476T1 (xx) 1998-06-22
BG63917B1 (bg) 2003-06-30
DK0863880T3 (da) 2004-03-22
LT98047A (en) 1998-10-26
SK21698A3 (en) 1998-10-07
NO313829B1 (no) 2002-12-09
UA46790C2 (uk) 2002-06-17
CA2184871C (en) 2001-08-21
ATE254606T1 (de) 2003-12-15
AR003502A1 (es) 1998-08-05
CA2184871A1 (en) 1997-03-06
HU225956B1 (en) 2008-01-28
NZ315624A (en) 1998-11-25
CZ291839B6 (cs) 2003-06-18
TW422838B (en) 2001-02-21
ES2208758T3 (es) 2004-06-16
CN1103762C (zh) 2003-03-26
DE19532668A1 (de) 1997-03-06
AU6737596A (en) 1997-03-27
JPH11512101A (ja) 1999-10-19
NO980906L (no) 1998-03-02
IL123333A (en) 2001-10-31
IL123333A0 (en) 1998-09-24
BG102287A (en) 1998-09-30
HK1015776A1 (en) 1999-10-22
EA000535B1 (ru) 1999-10-28
EA199800271A1 (ru) 1998-10-29
CN1200728A (zh) 1998-12-02
WO1997009314A1 (de) 1997-03-13
FR13C0049I1 (pt) 2013-09-27
PL188287B1 (pl) 2005-01-31
GEP20022652B (en) 2002-03-25
HUP9802941A2 (hu) 1999-09-28
NO980906D0 (no) 1998-03-02
FR13C0049I2 (fr) 2014-03-28
PT863880E (pt) 2004-04-30
SK284868B6 (sk) 2006-01-05
LT4482B (lt) 1999-03-25
HUP9802941A3 (en) 1999-10-28
JP4030578B2 (ja) 2008-01-09
LU92263I2 (fr) 2013-10-07
AU700602B2 (en) 1999-01-07
EE03562B1 (et) 2001-12-17
MX9801742A (es) 1998-08-30

Similar Documents

Publication Publication Date Title
PT750907E (pt) Formulacoes de vacinas estaveis para administracao parenterica metodo para a sua utilizacao e processo para a sua preparacao
BR9000489A (pt) Conecao de mangueira e processo para a sua fixacao
BR9612135A (pt) Taxóides processo para sua preparação e composiç o farmacêutica
PT799866E (pt) Negro-de-fumo e processo para a sua preparacao
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
BR9610202A (pt) Folha de reflexão e processo para sua produção
PT780390E (pt) Modificacao cristalina do cdch processo para a sua producao e preparacoes farmaceuticas que o contem
BR9603072A (pt) Agente de tratamento do cabelo e processo para a sua preparação
BR9503512A (pt) Composto organometálico e processo para a sua preparaçao
BR9606396A (pt) Derivados de camptotecin substituídos e processo para sua preparação
BR8906417A (pt) Composicao de detergente e processo para sua preparacao
PT815074E (pt) Compostos de o-carbamoil-(d)-fenilalanilol e processo para a sua preparacao
BR9600147A (pt) Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso
BR9606328A (pt) Derivado de benzilsulfeto processo para sua preparação e praguicida
BR9401642A (pt) Restaurador de cabelos e processo para sua preparação
BR9611466A (pt) Vacinas de tumores e processo para a sua preparação
BR9301652A (pt) Dispersoes peroladas aquosas capazes de escoar e processo para a sua preparacao
BR9612281A (pt) Processo para preparação de um 1,2-bis(aciloóxilato) e de um 3,4-diacetóxi-1-buteno
BR9602983A (pt) Gel e processo para sua preparação
PT900253E (pt) Composicoes de betume e um processo para a sua preparacao
BR9601998A (pt) Dispersões aquosas de organopoliisiloxanos processo para sua preparação e aplicação
PT839138E (pt) Processo para a preparacao de 3-hidroxipirazois substituidos em n
BR9206784A (pt) Copolímero bloco de aramida e processo para sua preparação
BR9610359A (pt) 1.ar(alqu)il-imidazolin-2-onas de ação anticonvulsiva que contêm um radical amino dissubstituído em posição 4 e processo para sua preparação
BR9301448A (pt) Composicao e processo para sua preparacao

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ELBION AG (DE)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/03/2007, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: ELBION GMBH (DE)

Free format text: NOME ALTERADO DE: ELBION AG

B25D Requested change of name of applicant approved

Owner name: BIOTIE THERAPIES GMBH (DE)

Free format text: NOME ALTERADO DE: ELBION GMBH

B25A Requested transfer of rights approved

Owner name: BIOCREA GMBH (DE)

Free format text: TRANSFERIDO DE: BIOTIE THERAPIES GMBH

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061162/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132252-414.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: ASTELLAS PHARMA INC., AVENTIS PHARMA S.A, BIOCREA GMBH, BRACCO S.P.A, CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA